Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

at ASH include:

  • Tasigna data showing its benefit in the first-line treatment setting for patients with chronic myeloid leukemia, in two oral presentations (ASH Abstracts #181 & 446; Monday, December 8, 2008; 7:00 AM PST & 1:45 PM PST, respectively)
  • Cardiac data from the landmark EPIC trial, demonstrating significant benefit with Exjade in patients with transfusion-dependent anemias (ASH Abstract #3873; Monday, December 8, 2008; 5:30 PM PST). More than ten additional abstracts from the EPIC trial in patients with different underlying anemias will also be presented
  • RAD001 data demonstrating benefit in patients with relapsed and/or refractory Waldenstrom Macroglobulinemia(ASH Abstract #1011; Saturday, December 6, 2008; 5:30 - 7:30 PM PST)
  • More than 10 abstracts on panobinostat (LBH589), showing early activity across a broad range of cancers, including acute myeloid leukemia, cutaneous t-cell lymphoma, multiple myeloma and mantle cell lymphoma

The most significant presentations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) will include:

  • New data, presented in an oral session, from major international BIG 1-98 trial evaluating Femara vs. tamoxifen and the sequencing of the two therapies show evidence of optimal treatment strategy for postmenopausal women with breast cancer (SABCS Abstract #13; Thursday, December 11, 2008; 9:45 - 10:00 AM CST)
  • The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response - exploratory evidence for direct anti-tumor activity in breast cancer (AZURE subgroup analysis) (SABCS Abstract #5101; Saturday, December 13, 2008; 5:00 - 7:00 PM CST). A total of nine Z
    '/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Fenwal Inc., a global medical technology company focused ... announced today that the U.S. Food and Drug ... ® platelet additive solution. Fenwal ® ... product used in combination with human plasma to ... to prevent or treat bleeding. ,, InterSol ® ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Systemic Lupus ... Market Forecasts to 2015 ,, ... Lupus Erythematosus - Drug Pipeline Analysis ... Summary ,, GlobalData, the ...
(Date:12/15/2009)... -- EnzySurge Ltd.,(EnzySurge), a provider of innovative ... announced today that it has received clearance ... to market its new,SilverStream(TM) solution for prescription ... version of the SilverStream product. , ... of the DermaStream(R) product line.,DermaStream is a ...
Breaking Medicine Technology:Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 1Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 3Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 4Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 1Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 2Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 3Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 1Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 2Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 3
... to President Obama,s call for "a cure for cancer ... America (PhRMA) delivered a new report today on medicines ... that America,s pharmaceutical research and biotechnology companies are testing ... medicines listed in the report are being tested in ...
... We may introduce the first,"A"- Implant novelty from Austria: , , ... - two-part system, - extraordinary stability, ... reliable Zirconium oxide, - Manufactured for your individual odontotherapy!, ... After 4 years of research and technical development, the team ...
Other Medicine Technology:New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 2New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 3New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 4
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., ... that, "it doesn,t matter whether there,s a public option. ... public option - give government authority over how your ... new social agenda by shifting billions of dollars from ... immigrants, and local politicians." ,, Betsy McCaughey ...
(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, made by ... was highly praised by treadmill review groups in recent ... TR200 folding treadmill received awards for Best New Treadmill, ... ,, The compact LifeSpan TR200 treadmill is designed for ... category buster is a very compact treadmill that could ...
(Date:12/15/2009)... Strike Force Operations Lead to Indictment of 30 ... more than $61 Million in Fraudulent Billing to ... -- Thirty people have been charged in three ... submit more than $61 million in false Medicare ... the Medicare Fraud Strike Force, Department of Health ...
(Date:12/15/2009)... new study links chronic obstructive pulmonary disease, or COPD, ... to activate the body,s immune system. , The ... growing awareness of the immune system,s role in COPD, ... 12 million Americans with wheezing, shortness of breath, chest ... if doctors are to find better ways to detect ...
(Date:12/15/2009)... United Nations Foundation has led the fight against malaria, ... Report 2009 that the global strategies for ending malaria deaths are ... the United Nations Foundation , ... Washington, D.C. (Vocus) ... Nations Foundation has led the fight against malaria, and I ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2
... PMD ) today announced that Jennifer Chmieleski ... Jennifer will be responsible for all internal and ... analysis and planning,activities necessary for the company,s continued ... CEO. Since 1999, Jennifer has served as ...
... ... management support circle, ALEXANDRIA, Va., Oct. 4 ... tool that,makes it easier for people with diabetes -- and ... to improve their diabetes,care. The tool, My Diabetes Connector, is ...
... 4 Diet.com has joined Microsoft Corp. ... newly launched Microsoft,HealthVault consumer health platform. ... include,Diet.com Calorie/Meal Tracker, Diet.com Weight Tracker, and ... HealthVault. The trackers will,enable users to share ...
... (Nasdaq: GNTA ) announced today that the Company,s ... will provide an,update of corporate activities at the BIO ... PDT. The conference will be held at The,Palace hotel ... webcast and accessible at the Investor,Relations section of the ...
... developed for the industry, PHILADELPHIA, Oct. ... division, announced today that it is among ... new Pharmacy Benefit,Management Standards. Nearly 70 ... pharmacy benefit management companies. URAC accreditation provides,assurance ...
... Institute of Child Health and Human Development (NICHD) announced ... was awarded a competitive contract to participate in the ... be conducted in the United States to assess the ... human health. The study will follow 100,000 children from ...
Other Medicine News:Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4Health News:Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 3Health News:PerformRx Earns New URAC Accreditation for Pharmacy Benefit Management 2Health News:UMASS Medical School awarded National Children's Study contract 2Health News:UMASS Medical School awarded National Children's Study contract 3Health News:UMASS Medical School awarded National Children's Study contract 4
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Medicine Products: